Merck’s bid to update Winrevair’s label advances with FDA priority review, backed by Phase III ZENITH data showing a 76% ...

Digital inhalers may help predict occurrence of acute exacerbations of COPD for patients in an ambulatory setting.

While it trails Johnson & Johnson’s Tecvayli, Regeneron still hopes Lynozyfic can differentiate in terms of dosing ...

Research shows that digital inhalers equipped with remote monitoring capabilities may aid in predicting and identifying ...

With the demand for affordable health care rising across Ohio, health officials are cautioning that funding for free and ...

UCLA researchers have successfully grown miniature lungs from stem cells—complete with their own functioning blood vessel ...

Pulmonary rehabilitation is initiated and completed by a greater proportion of patients with IPF vs COPD or other chronic respiratory disorders.

Breakthrough bioconvergence platform detects inflammatory events prior to symptoms, partnering with Altesa Biosciences to ...

The Cardiac Centre at Al Qassimi Hospital, operated by Emirates Health Services (EHS), has become the first facility in the ...

Bronchiectasis causes your airways, called bronchi, to become damaged and widened over time. When you have bronchiectasis, ...

Columnist Caroline Gainer weighs in on how changes with her doctors have affected her ability to coordinate care for her COPD ...

Currently available treatments for IPF are limited to only two approved drugs that come with significant side-effects, ...